Lung cancer 'overtaking breast cancer in European women'

Key points
- Lung cancer is set to overtake breast cancer as the biggest cause of female cancer death in Europe, say experts.
- This is already the case in the UK and Poland, the Annals of Oncology reports.
- The rise reflects a surge in the number of women who started smoking in the 1960s and 1970s, the experts say.
- The lung cancer death rate will continue on its upward trend for the next few years - but with fewer young European women now starting to smoke, it should decrease with time.
Lung cancer is set to overtake breast cancer as the biggest cause of female cancer death in Europe, say experts.
This is already the case in the UK and Poland, the Annals of Oncology reports.
The rise reflects a surge in the number of women who started smoking in the 1960s and 1970s, the experts say.
The lung cancer death rate will continue on its upward trend for the next few years - but with fewer young European women now starting to smoke, it should decrease with time.
In 2013, some 82,640 European women will die from lung cancer, while 88,886 will die from breast cancer.
And by 2015 the balance will have shifted and lung cancer will take the lead, according to Prof Carlo La Vecchia and colleagues.
European snap shot
They looked at cancer rates for the EU as a whole (27 member states as at 2007) and also in six individual countries - France, Germany, Italy, Poland, Spain and the UK - for all cancers, and, individually, for stomach, intestine, pancreas, lung, prostate, breast, uterus (including cervix) and leukaemias.
For lung cancer, we expect death rates to start to go down in around 2020 or 2025 now that the new generation of women are smoking less” Lead researcher Prof Carlo La Vecchia
Figures show that although more and more people are developing cancer - because they are living longer - overall, fewer are dying from the disease.
Despite the decline in total cancer deaths, lung cancer death rates continue to rise among women in all EU countries.
The number of pancreatic cancer deaths among both men and women also shows no sign of decreasing, largely because there are few effective treatments for this type of cancer.
Prof La Vecchia, of the University of Milan, Italy, said: "This is worrying. It is the single major cancer that does not show any signs of declining in the future, despite fewer people smoking.
"Smoking and diabetes account for about a third of cases. But we do not know what causes most of the rest.
"But for lung cancer, we expect death rates to start to go down in around 2020 or 2025 now that the new generation of women are smoking less."
Sarah Williams, of Cancer Research UK, said: "It's encouraging to see that overall the rate of people dying from cancer in Europe is predicted to continue falling.
"This reflects improvements in what we know about how to prevent, diagnose and treat cancer and shows that through research we are making inroads against the disease.
"But deaths from lung cancer in women are still rising, reflecting smoking rates in previous decades, so sadly most of these deaths were avoidable.
"These figures underline the importance of reducing the number of people who smoke - both through helping smokers to quit and by introducing plain, standardised packaging to give young people one less reason to start.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsUGR scientists patent an effective drug for treating breast, colon, and skin cancers
Scientists from the University of Granada (UGR) have patented an effective drug for treating cancer stem cells (CSCs) in breast, colon, and skin cancers. The researchers have proved the anti-tumor effects of the drug on…
21 October 2015
GuideDecoding the microbial signature of aggressive form of breast cancer
Cancer is a result of normal cellular functions going wildly awry on a genetic level. That fact has been known for some time, but increasing evidence is showing that the human microbiome, the diverse population of…
16 October 2015
NewsRare mutation may extend survival in lung cancer patients with brain metastases
New Haven, Conn. -Most patients with non-small cell lung cancer (NSCLC) that has metastasized to the brain have a dire prognosis. But Yale researchers have identified a subset of those patients with a rare genetic…




